| Financial Year |
March 31 2023 |
| Monetary Funds |
2,157,573,771.54 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
25,600,776.98 |
| Accounts Receivable |
237,210,649.71 |
| Advances to Suppliers |
332,987,580.54 |
| Other Receivables |
4,318,658.62 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,980,723,110.11 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
16,742,970.42 |
| Other Current Assets |
44,954,973.92 |
| Total Current Assets |
4,904,013,883.17 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
18,049,087.50 |
| Long-term Equity Investment |
1,924,121,414.26 |
| Investment Properties |
-- |
| Fixed Assetes |
10,984,179,620.39 |
| Under-construction Projects |
1,453,277,739.23 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,778,212,580.16 |
| R&D expenses |
-- |
| Goodwill |
1,744,566.20 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
37,748,042.70 |
| Other Non-Current Assets |
215,785,755.78 |
| Sub-Total of Non-Current Assets |
16,469,054,868.97 |
| Total Assets |
21,373,068,752.14 |
| Short-Term Loans |
1,938,135,715.29 |
| Trading Financial liabilities |
-- |
| Notes Payable |
3,158,378,666.66 |
| Accounts Payable |
1,408,302,974.48 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
109,746,328.29 |
| Taxes Payable |
65,378,715.10 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
116,484,776.86 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,091,816,639.87 |
| Other Current Liabilities |
95,913,998.80 |
| Sub-Total of Current Liabilities |
8,709,849,795.89 |
| Long-term Loans |
957,940,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
620,915,712.71 |
| Special Payable |
-- |
| Estimatied Liabilities |
16,897,368.36 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,613,864,203.13 |
| Total Liabilities |
10,323,713,999.02 |
| Paid-In Capital(Or Share Stock) |
2,042,497,639.00 |
| Capital Surplus |
4,005,291,204.77 |
| Surplus Reserve |
301,895,933.18 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,444,884,787.27 |
| Minority Stockholder's Interest |
2,230,363,948.21 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,818,990,804.91 |
| Owner's Equity（Stockholder's Equity） |
11,049,354,753.12 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
21,373,068,752.14 |
